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To the Editor,
 
We report a case with idiopathic thrombocytope-
nic purpura (ITP) who had venous thrombosis. A 
59-year-old man with ITP was referred to our hospital 
because of chest pain. We planned splenectomy after 
intravenous immunoglobulin (IVIG) treatment 
because he showed no response to corticosteroid. 
During IVIG treatment and after splenectomy, venous 
thrombosis occurred. He was found heterozygous for 
factor V Leiden, prothrombin (PT) 20210 G>A and 
methyltetrahydrofolate reductase (MTHFR) C677T.
Idiopathic thrombocytopenic purpura (ITP) is an 
acquired autoimmune disorder characterized by 
thrombocytopenia and mucocutaneous bleeding 
and it may occur acutely, chronically or recurrently. 
While the acute form of the disease is seen in child-
hood, the chronic form is generally seen in adults. 
Splenectomy is recommended for patients who do 
not respond to primary therapy (glucocorticoids, 
IVIG and/or anti-D) and who have clinical symptoms 
of bleeding when there is no contraindication for 
surgery. Thromboembolic complications after sple-
nectomy are described in 10% of patients with ITP 
and may be seen as portal vein thrombosis, pulmo-
nary embolism or crural deep vein thrombosis [1].
A 59-year-old man was referred to our hospital 
because of chest pain. No peripheral lymphade-
nopathy or petechial or purpuric lesions were deter-
mined on his physical examination. Routine labora-
tory tests showed thrombocytopenia (4000/mm3) 
confirmed by peripheral blood smear. Etiologic 
tests were as follows: HBs Ag: (-), antiHBs: (-), anti-
HCV: (-), antiHIV: (-), antinuclear antibody (ANA): 
(-), anticardiolipin IgM: 3.1 (0-7) MPL U/ml, and anti-
cardiolipin IgG: 3.2 (0-10) GPL U/ml. Abdominal 
ultrasonography showed no organomegaly or 
lymphadenopathy. Bone marrow aspiration smear 
analysis showed that development of myeloid and 
erythroid series was normal, both young and mature 
forms of megakaryocytes were seen, and counts 
were elevated. Platelet release was decreased. We 
accepted this case as ITP . Since his platelet count 
showed no response to oral prednisolone treat-
ment,  pulse steroid was administered at a dose of 
1 g/day for 3 days, but again there was no response 
in platelet count, and splenectomy was planned. In 
the preoperative period just after IVIG treatment, 
pain and hyperemia associated with the venous 
catheter line developed. Upper extremity Doppler 
ultrasonography showed acute thrombosis in the 
left brachial and axillary veins. At this time, his thrombocyte count was 18,000/mm3. Although IVIG 
can rarely cause deep vein thrombosis, we studied 
all thrombophilic tests. Results of these tests were 
as follows: protein S: 82 (6-140%), protein C: 122 
(70-140%), antithrombin III (ATIII): 139 (80-120), 
lupus anticoagulant: 34.2 (20-60), and fasting homo-
cysteine: 10.36 (4.5-15) umol/L. At the one-month 
follow-up after splenectomy, he complained of 
swelling and pain on his right leg. Doppler ultraso-
nography showed acute-subacute thrombosis in the 
right popliteal and left saphenous veins. At this time, 
his platelet count was 230,000/mm3. He was found 
heterozygous for factor V Leiden, PT 20210 G>A 
and MTHFR C677T genes. We planned anticoagula-
tion with lifelong warfarin.
In patients presenting with thrombocytopenia, 
diagnosis of ITP is made by exclusion of conditions 
that may cause thrombocytopenia, which include: 
drug use (generally heparin, alcohol, quinine/quini-
dine, sulphonamides), bacterial infections, viral 
infections (HIV, hepatitis, cytomegalovirus, Epstein-
Barr virus), rickettsia infections, mycoplasma infec-
tions, lymphoproliferative diseases (chronic lym-
phocytic leukemia, large granular lymphocytic leu-
kemia, lymphoma), autoimmune diseases (espe-
cially systemic lupus erythematosus, antiphospho-
lipid antibody (APA) syndrome), disseminated intra-
vascular coagulopathy, hemolytic uremic syndrome, 
thrombotic thrombocytopenic purpura, preeclamp-
sia/eclampsia, HELLP syndrome, gestational throm-
bocytopenia, and hypersplenism. Patients who 
develop thrombosis after presenting with thrombo-
cytopenia should be investigated for APA syndrome. 
This syndrome is characterized by thrombosis in the 
arterial and venous systems and persistently high 
levels of antiphospholipid antibodies. APA syn-
drome is a multisystem disease that may be accom-
panied by thrombocytopenia and recurrent fetal 
losses. In our case, both anticardiolipin antibodies 
and lupus anticoagulant levels were normal at the 
time of diagnosis. Our patient was taking IVIG when 
the first thrombosis attack occurred. Especially 
thromboembolic events may be seen in patients 
with advanced age, diabetes mellitus, hypertension, 
and dyslipidemia or in patients given high doses of 
IVIG rapidly [2]. Thromboembolic events have been 
reported in 10% of patients undergoing splenecto-
my for hematologic diseases. Causes of thrombosis 
seen in these patients have not been clarified yet. 
The reported etiologic factors are damage to the 
portal vein and mesenteric veins during operation, 
hypercoagulability (protein C, protein S, ATIII defi-
ciency, etc.) and postsplenectomy thrombocytosis. 
In addition, according to some studies, hematologic 
disease and spleen size may play a role in thrombo-
sis development. Postsplenectomy portal vein and 
mesenteric thrombosis is most often seen following 
splenectomy for myeloproliferative disorders and 
almost never after trauma [3-5]. Because our patient 
had thrombosis attacks in the upper and lower 
extremities, although he was thrombocytopenic 
when the first attack occurred, we investigated 
hereditary thrombophilia and found three heredi-
tary thrombophilic risk factors. Thus, anticoagulant 
therapy was planned despite his advanced age. 
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